Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

Kentucky medical scientist wins AHA Achievement Award for “extraordinary contributions” to cardiovascular research

The American Heart Association has presented its Research Achievement Award for 2013 to Roberto Bolli, M.D., of the University of Louisville, “for the profound and lasting impact of his extraordinary contributions to cardiovascular research.”

November 18, 2013

Pittsburgh scientist awarded American Heart Association prize for leadership of worldwide effort to clarify CVD risk in populations

The American Heart Association has awarded its 2013 Population Research Prize to Lewis H. Kuller, M.D., Dr.P.H., of Pittsburgh, “for 40 years of inspired leadership of a worldwide effort to better understand and prevent heart disease and stroke in populations.”

November 18, 2013

Cincinnati researcher awarded American Heart Association prize for advancing knowledge of cardiovascular disease in children

The American Heart Association today awarded its Basic Research Prize for 2013 to pediatric cardiologist and researcher Jeffrey A. Towbin, M.D., of Cincinnati, for “highly significant additions to our basic knowledge of cardiovascular disease in children.”

November 18, 2013

Will guidelines quash drugs in the pipeline?

New guidelines for managing patients’ cholesterol won’t greatly affect the statin industry, the New York Times reported, but they could put a damper on new classes of drugs under development such as PCSK9 inhibitors.

November 15, 2013

First live Case with innovative transapical access technology at EACTS

The use of Apica's innovative transapical access technology was successfully demonstrated for the first time at the 27th European Association for Cardio-Thoracic Surgery (EACTS) congress in Vienna. EACTS is one of the largest cardiac congress in the world, with around 6,500 participants.

November 13, 2013

George Magovern, pioneering surgeon, dies at 89

George J. Magovern, MD, a pioneering cardiac surgeon who co-developed the sutureless Magovern-Cromie Heart Valve, died Nov. 4 at the age of 89. His obituary was published on Pittsburgh’s post-gazette.com website.

November 7, 2013

Acusphere appoints Dr. William Ramage as chief development officer

Acusphere, Inc. (ACUSD.PK) today announced that William I. Ramage, D. Phil., has been appointed Chief Development Officer of the Company. Acusphere is focused on the development of Imagify™ (Perflubutane Polymer Microspheres for Injectable Suspension), which if approved for sale, will be a novel cardiovascular drug for the detection of coronary artery disease (CAD), the leading cause of death in the United States and Europe.

November 6, 2013

Encouraging a healthy weight for a healthy heart

A healthy weight is the key to a healthy heart, and yet an estimated 1 out of 3 children is either overweight or obese in the U.S. During a special symposium Oct. 27 at the American Academy of Pediatrics National Conference and Exhibition in Orlando, pediatricians discussed obesity and cardiovascular risk factors, public health policy, and how physicians can partner with families to improve children's weight.

October 29, 2013

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup